Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Unicycive Therapeutics, Inc. (UNCY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| Aggarwal Gaurav (Director) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Converted 3,470,152 shares
@ $0
Converted 8,077 preferred shares
@ $1000, valued at
$8.1M
Converted 13,429,000 preferred shares
@ $0
Converted 12,802,388 options to buy
@ $0.539, valued at
$6.9M
Converted 11,638,534 options to buy
@ $0.5929, valued at
$6.9M
Converted 18,621,655 options to buy
@ $0.7411, valued at
$13.8M
|
|
| 07/13/2023 |
4
| Jermasek Douglas (EVP of Corporate Strategy) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Exercised 104,612 shares
@ $0
Exercised 50 convertible preferred
@ $0.49, valued at
$24.5
Exercised 79,252 options to buy
@ $0.54, valued at
$42.8k
Exercised 72,047 warrants
@ $0.59, valued at
$42.5k
Exercised 115,275 warrants
@ $0.74, valued at
$85.3k
|
|
| 07/13/2023 |
4
| Gupta Pramod (EVP, Pharmaceuticals and BD) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Exercised 41,845 shares
@ $0
Exercised 20 convertible preferred
@ $0.49, valued at
$9.8
Exercised 31,700 options to buy
@ $0.54, valued at
$17.1k
Exercised 28,818 warrants
@ $0.59, valued at
$17k
Exercised 46,110 warrants
@ $0.74, valued at
$34.1k
|
|
| 07/13/2023 |
4
| Gupta Shalabh K. (CEO) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Exercised 104,612 shares
@ $0
Exercised 50 convertible preferred
@ $0.49, valued at
$24.5
Exercised 79,252 options to buy
@ $0.54, valued at
$42.8k
Exercised 72,047 warrants
@ $0.59, valued at
$42.5k
Exercised 115,275 warrants
@ $0.74, valued at
$85.3k
|
|
| 03/09/2023 |
4
| Aggarwal Gaurav (Director) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 8,077 convertible preferred
@ $1000, valued at
$8.1M
|
|
| 03/09/2023 |
4
| Gupta Shalabh K. (CEO) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 50 convertible preferred
@ $1000, valued at
$50k
|
|
| 03/09/2023 |
4
| Gupta Pramod (EVP, Pharmaceuticals and BD) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 20 convertible preferred
@ $1000, valued at
$20k
|
|
| 03/09/2023 |
4
| Jermasek Douglas (EVP of Corporate Strategy) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 50 convertible preferred
@ $1000, valued at
$50k
|
|
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2022 |
4
| Schiller Brigitte (Director) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Exercised 26,738 restricted stock units
@ $0 |
|
| 05/17/2022 |
4
| Schiller Brigitte (Director) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Bought 15,000 shares
@ $0.825, valued at
$12.4k
|
|
| 07/26/2021 |
4
| Gupta Shalabh K. (CEO) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 116,279 options
@ $5, valued at
$581.4k
|
|
| 07/26/2021 |
4
| Gupta Pramod (EVP, Pharmaceuticals and BD) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 34,884 options
@ $5, valued at
$174.4k
|
|
| 07/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|